United Kingdom & Bleichmar Fonti & Auld LLP
2 shared events · Importance 3 · Last updated Jul 31, 2026
Live sentiment trends, interaction importance charts, and action volume tracking available on the
Ergen Dashboard
Regulatory
United Kingdom: The United Kingdom's United Kingdom — National Health Service (NHS) was involved in the NHS-Galleri trial, which is central to the class action lawsuits against Illumina — Holy Grail, Inc.
Bleichmar Fonti & Auld LLP: Bleichmar Fonti & Auld LLP is one of the law firms that filed the class action lawsuit against Illumina — Holy Grail, representing investors.
Jun 05, 2026 · 315 articles
Regulatory
United Kingdom: The United Kingdom is where the NHS-Galleri trial was conducted. The trial's failure may have implications for UK cancer screening initiatives.
Bleichmar Fonti & Auld LLP: BFA filed a class action lawsuit against Illumina — Holy Grail and certain executives, alleging securities fraud related to the NHS-Galleri trial. The firm is actively soliciting investors to join the case.
Jun 09, 2026 · 192 articles
ERGEN INTELLIGENCE
Explore this relationship live
Track how United Kingdom and Bleichmar Fonti & Auld LLP interact across events, view sentiment trends, and discover connected entities.
Open Dashboard